Navigation Links
Depression and anxiety disorders of adolescents are not the same thing
Date:9/23/2009

Adolescent depression and anxiety disorders are two distinct psychiatric disorders, according to Dr. William W. Hale III (a researcher of the Langeveld Institute for the Study of Education and Development in Childhood and Adolescence at Utrecht University) in a recent publication in the Journal of Child Psychology and Psychiatry.

Hale and his colleagues conducted a five-year, longitudinal study of secondary school adolescents. Every year the depressive and anxiety disorder symptoms of the adolescents were measured. Hale and his colleagues concluded that while adolescent anxiety and depression were strongly related to one another, that adolescent depression and anxiety disorder symptoms are in fact best classified as two distinct disorders.

DSM-V

These conclusions are of importance for the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) that is planned for publication in 2012. Adolescent depression and anxiety disorders are presently classified in the revised fourth edition of the DSM (DSM-IV-TR), however it has been suggested that these two disorders be given a join classification in the DSM-V. Hale argues that the present-day classification of adolescent depression and anxiety disorders be preserved in the DSM-V.


'/>"/>

Contact: Bill Hale
b.hale@uu.nl
Wiley-Blackwell
Source:Eurekalert

Page: 1

Related biology news :

1. Genetic factors may predict depression in heart disease patients
2. Team identifies a molecular switch linking infectious disease and depression
3. Mothers of multiple births at increased odds of postpartum depression
4. Researchers take first look at the genetic dynamics of inbreeding depression
5. Children seriously affected when a parent suffers from depression
6. Chantix side effects no worse with depression history
7. Pregnancy hormone predicts postpartum depression
8. Depression during pregnancy can double risk of preterm delivery
9. Coming soon: Self-guided, computer-based depression treatment
10. Coating improves electrical stimulation therapy used for Parkinsons, depression, chronic pain
11. Likely cause of postpartum blues and depression identified
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2016)... 2016 --> --> Fourth ... (105.0), up 1,187% compared with fourth quarter of 2014. Gross ... M (loss: 30.0). Earnings per share increased to SEK 6.39 ... M (neg: 74.7). , --> ... SEK 2,900.5 M (233.6), up 1,142% compared with 2014. Gross ...
(Date:2/3/2016)... , Feb. 3, 2016 ... the addition of the "Emotion Detection ... Machine Learning, and Others), Software Tools (Facial ... Areas, End Users,and Regions - Global forecast ... --> http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has ...
(Date:2/2/2016)... 2, 2016 Checkpoint Inhibitors for Cancer ... Are you interested in the future of ... checkpoint inhibitors. Visiongain,s report gives those predictions to ... national level. Avoid falling behind in data ... and revenues those emerging cancer therapies can achieve. ...
Breaking Biology News(10 mins):
(Date:2/5/2016)... 2016  In the pharmaceutical industry the medical affairs ... launch activities including the identification and engagement of key ... especially high in the oncology therapeutic area where most ... the Role of Medical Affairs in Oncology Launch Excellence ... therapies find better ways to utilize medical affairs to ...
(Date:2/5/2016)... -- Amarantus BioScience Holdings, Inc. ... products for Regenerative Medicine, Neurology and Orphan Diseases, announced ... from the US Food and Drug Administration (FDA) for ... granted orphan drug designation (ODD) by the US FDA ... Inc. (OTCQB: AMBS), a biotechnology company ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... compliance training, today announced an interactive FDA compliance training course, ... (Regulatory Affairs Professional Society) accredited interactive course on Morf Playbook—now conveniently available on ...
(Date:2/4/2016)...  Sangamo BioSciences, Inc. (NASDAQ: SGMO ), the ... Edward Lanphier , Sangamo,s president and chief executive officer, ... ZFP Therapeutic ® development programs and an overview ... on Thursday, February 11, 2016, at the Leerink Partners ... is being held in New York ...
Breaking Biology Technology: